BIOMAT Database Logo BIOMAT Database Logo

Role of urinary arginine vasopressin in the sodium excretion in patients with chronic renal failure. 1996

H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Third Department of Internal Medicine, Kumamoto University School of Medicine, Japan.

Patients with chronic renal failure show almost equal levels of sodium excreted in the urine as healthy subjects through an increase of the fractional excretion sodium (FE(Na)). The mechanisms of this adaptation, however, are unknown. Recently, urinary arginine vasopressin (AVP) has been shown to inhibit the antidiuretic action of plasma AVP in the collecting ducts of rabbits and rats. In this article, the roles of plasma and urinary AVP are examined with other hormones in the sodium excretion of 57 patients with chronic renal disease. The fractional excretion of AVP, plasma atrial natriuretic peptide (ANP) and endothelin-1 (ET-1), urinary ET-1, and FE(ET-1) correlated with the decrease of creatinine clearance (Ccr). Multiple and stepwise regression analyses showed that FE(AVP) is the major dependent determinant for FE(Na) (adjusted r2 = 0.78). These results suggest that the increase of AVP excretion per remaining nephron could be a cause of the increase of FE(Na) in patients with renal failure. Although plasma AVP works as an antidiuretic hormone, urinary AVP serves as an intrinsic diuretic, especially in patients with chronic renal failure.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Correlation between Urinary Excretion of Arginine-Vasopressin and Renal Reabsorption of Sodium and Water.
February 2019, Bulletin of experimental biology and medicine,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Arginine vasopressin mediates the chloroquine induced increase in renal sodium excretion.
August 1996, Tropical medicine & international health : TM & IH,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Atrial natriuretic peptide and adaptation of sodium urinary excretion in patients with chronic renal failure.
September 1988, Clinical science (London, England : 1979),
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Sodium excretion in human pregnancy: a role for arginine vasopressin.
April 1986, American journal of obstetrics and gynecology,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Renal excretion of arginine-vasopressin in microalbuminuric diabetic patients.
January 1989, Advances in experimental medicine and biology,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure.
September 1978, Kidney international,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Regulation of plasma arginine vasopressin in patients with chronic renal failure maintained on hemodialysis.
January 1986, American journal of nephrology,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
January 1997, Renal failure,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
[Plasma atrial natriuretic peptide level and urinary fractional sodium excretion (FENa) in patients with chronic renal failure].
December 1990, Polskie Archiwum Medycyny Wewnetrznej,
H Nonoguchi, and M Takayama, and A Owada, and K Ujiie, and T Yamada, and O Nakashima, and Y Sakuma, and J Koike, and Y Terada, and F Marumo, and K Tomita
Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
January 1993, Clinical science (London, England : 1979),
Copied contents to your clipboard!